The Stemcentrx brand, founded in 2008 (United States), from 110 sister brands and 17477 competing brands. Stemcentrx is owned by ABBVIE INC., listed on the stock exchange of New York Stemcentrx belongs to the Drug Manufacturers business sector.
Investment simulator :
Portfolio valuation
ABBVIE INC.
(Stemcentrx)
over 5 years*
USD 404.30